论文部分内容阅读
目的：了解胆道引流治疗不能切除的胆管癌的治疗效果。方法：分析经胆道引流手术治疗的不能切除的胆管癌80例的临床资料及生存情况，其中肝门部胆管癌49例（61.3％），胆总管中上段癌9例（11．2％），胆总管下段癌22例（27．5％）.手术方式包括胆肠吻合的内引流术，U或T管外引流，或两者联用。结果：15％的病例术后早期出现并发症，手术死亡率为10％。术后随访：肝门部胆管癌、胆总管中上段癌及胆总管下段癌中位生存期分别为6．10、5．50和9．50个月。胆总管中上段癌无1年以上生存者，肝门部胆管癌和胆总管下段癌1、2、3年生存率分别为27．39％、38．54％，6．59％、8．97％和2．10％、0。结论：胆道引流手术是治疗不能切除胆管癌的一种重要方法，可获良好的姑息治疗效果。
Objective: To understand the therapeutic effects of biliary drainage for unresectable cholangiocarcinoma. Methods: The clinical data and survival of 80 patients with unresectable cholangiocarcinoma treated with biliary drainage were analyzed. Among them, 49 (61.3%) were hilar cholangiocarcinoma, and 9 (11.2%) were middle and upper cholangiocarcinoma. Twenty-two cases (27.5%) of the common bile duct cancer were treated with internal drainage of biliary-enteric anastomosis, external U or T drainage, or a combination of the two. Results: Complications occurred early in the postoperative period in 15% of patients. The operative mortality rate was 10%. Follow-up: The median survival time of hilar cholangiocarcinoma, middle and upper common bile duct cancer, and common bile duct cancer were 6.10, 5.50, and 9.50 months, respectively. The 1-, 2-, and 3-year survival rates of hilar cholangiocarcinoma and lower common bile duct cancer were 27.39%, 38.54%, 6.59%, and 8.97, respectively. % and 2.10%, 0. Conclusion: Biliary tract drainage is an important method for the treatment of unresectable cholangiocarcinoma, and it can be used as a good palliative treatment.